Skip to main content

Table 1 Summary of baseline demographics of patients in the SENSCIS® trial

From: Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

 

Patients included in joint models (N = 574)a

Patients with all-cause hospitalisation events or death (n = 78)

Patients with SSc-related hospitalisation events or death (n = 42)

Patients with admission to ER or hospital followed by admission to ICU or death (n = 75)

Sex, n (%)

 Female

431 (75.1)

50 (64.1)

28 (66.7)

51 (68.0)

Age, years

53.9 ± 12.2

56.1 ± 12.0

56.1 ± 12.0

54.4 ± 11.6

Diffuse cutaneous SSc, n (%)

298 (51.9)

39 (50.0)

21 (50.0)

38 (50.7)

Time since the onset of the first non-Raynaud’s symptom, years

3.5 ± 1.7

3.5 ± 1.9

3.2 ± 2.0

3.6 ± 1.7

Extent of fibrosis of the lungs on HRCT, %

36.0 ± 21.2

35.9 ± 20.2

38.5 ± 21.2

36.3 ± 21.9

FVC, mL

2501.2 ± 778.2

2532.0 ± 787.2

2498.2 ± 817.2

2455.7 ± 693.5

FVC, % predicted

72.5 ± 16.7

72.0 ± 16.4

70.5 ± 18.7

70.9 ± 16.7

DLCO, % predictedb

53.1 ± 15.1

48.4 ± 13.2

47.7 ± 12.6

49.2 ± 13.5

ATA positive, n (%)c

349 (60.8)

42 (53.8)

24 (57.1)

43 (57.3)

mRSSd

11.1 ± 9.0

12.3 ± 11.1

13.2 ± 11.6

11.6 ± 9.0

Total score on the SGRQe

39.9 ± 20.4

44.3 ± 18.8

41.3 ± 19.9

47.9 ± 17.9

High-sensitivity C-reactive protein, mg/Lf

6.2 ± 15.2

10.6 ± 30.4

14.5 ± 40.5

10.6 ± 31.4

  1. Data are mean ± SD unless otherwise stated
  2. aData on some variables were not available for all patients
  3. bThe DLCO value was corrected for the haemoglobin level. DLCO values were available for 567 patients in total, 77, 41 and 74 patients with all-cause hospitalisation events or death, SSc-related hospitalisation events or death, and admission to ER or hospital followed by admission to ICU or death, respectively
  4. cHistorical information on ATA status was used, or, if this information was not available to the trial sites, it was provided by a central laboratory
  5. dScores were available for 572 patients in total, 77 and 74 patients with all-cause hospitalisation events or death, and admission to ER or hospital followed by admission to ICU or death, respectively
  6. eTotal scores on the SGRQ range from 0 to 100, with higher scores indicating worse health-related quality of life. Scores were available for 563 patients in total, 75 and 73 in patients with all-cause hospitalisation events or death, and admission to ER or hospital followed by admission to ICU or death, respectively
  7. fHigh-sensitivity C-reactive protein values were available for 529 patients in total, 71, 39 and 66 patients with all-cause hospitalisation events or death, SSc-related hospitalisation events or death, and admission to ER or hospital followed by admission to ICU or death, respectively
  8. ATA, anti-topoisomerase I antibody, DLCO, diffusing capacity of the lungs for carbon monoxide, ER, emergency room, FVC, forced vital capacity, HRCT, high-resolution computed tomography, ICU, intensive care unit, mRSS, modified Rodnan Skin Score, SD, standard deviation, SGRQ, St. George’s Respiratory Questionnaire, SSc, systemic sclerosis
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us